Boehringer Ingelheim has snagged former Novartis leader and Big Pharma vet Lykke Hinsch Gylvin, M.D., to serve as the company’s chief medical officer and head of global medicine.
Hinsch Gylvin has already assumed the position at the German pharma, per her Nov. 3 LinkedIn post. She brings more than 20 years of experience to the table, departing from her most recent role as Novartis’ vice president of global medical franchise and head of neuroscience. Before that, the leader held a four-year stint at AstraZeneca.
She also has past leadership experience at Roche, Novo Nordisk and Lundbeck.
Boehringer has been searching for a new CMO since Mehdi Shahidi, M.D., exited in February. The exec had been with Boehringer for more than 16 years and held the CMO title for three of them. He currently serves as chief medical expert at U.K.-based AI VIVO and as a venture partner for Medicxi Ventures.
“It’s so exciting to be part of this company as we share our passion to deliver innovative medicines to patients faster,” Hinsch Gylvin wrote on LinkedIn. “I am very much looking forward to working with my new colleagues and to continue transforming lives for generations.”